Key result
NHE-1 inhibition with EMD 87580 or AVE 4890 prevented cardiac glycoside-induced increases in cell surface area and atrial natriuretic peptide gene expression in rat ventricular myocytes.
Why the study?
Does NHE-1 inhibition prevent cardiac glycoside-induced hypertrophy in rat ventricular myocytes?
Does NHE-1 inhibition prevent cardiac glycoside-induced hypertrophy in rat ventricular myocytes?
NHE-1 inhibition attenuates the hypertrophic effects of cardiac glycosides in rat ventricular myocytes without affecting their inotropic actions.
Answers are grounded in this paper and cite their sources.
NHE-1 inhibition may counter glycoside-induced myocyte hypertrophy; hypothesis-generating in rats, requires in vivo and clinical validation.
AIMS: Cardiac glycosides induce cardiomyocyte hypertrophy via yet to be defined mechanisms. These hypertrophic effects are likely related to changes in intracellular signalling secondary to Na(+)-K(+) ATPase (NKA) inhibition which would produce elevations in intracellular sodium concentrations. Sodium-hydrogen exchanger isoform 1 (NHE-1) also contributes to intracellular sodium regulation. Accordingly, we determined the contribution of NHE-1 to cardiac glycoside-induced hypertrophy. METHODS AND RESULTS: The majority of the experiments were performed on cultured neonatal rat ventricular myocytes exposed to either ouabain (100 microM) or digoxin (40 microM) for 24 h, although additional experiments were also done using adult left ventricular myocytes with 30 microM of either glycoside. Both glycosides increased cell surface area by 30% and atrial natriuretic peptide gene expression by two- to three-fold (P < 0.05 for both). These effects were associated with a significant reduction in the expression of two NKA isoforms, alpha(2) and alpha(3), whereas the alpha(1) isoform was unaffected. Conversely, both glycosides increased NHE-1 expression in cardiomyocytes by approximately two-fold and significantly increased intracellular sodium concentrations by more than 60% (P < 0.05). Both ouabain and digoxin were also found to significantly increase phosphorylation of mitogen-activated protein kinases. All these effect were prevented when identical experiments were carried out in the presence of the NHE-1 inhibitors EMD 87580 or AVE 4890. Identical results were obtained using adult myocytes, although this was associated with downregulation of all three NKA isoforms. Glycoside-induced increase in cell shortening or intracellular Ca(2+) transients was not significantly affected by NHE-1 inhibition. CONCLUSION: When taken together, these studies show that NHE-1 inhibition attenuates the hypertrophic effect of cardiac glycosides without affecting inotropic parameters and suggest a possible approach to limiting glycoside-induced hypertrophic responses while preserving therapeutic, i.e. inotropic, actions.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2009) studied Cardiac glycoside-induced hypertrophy. NHE-1 inhibitors (EMD 87580 or AVE 4890) vs. Cardiac glycosides alone was evaluated on Cell surface area and atrial natriuretic peptide gene expression (p=< 0.05). NHE-1 inhibition with EMD 87580 or AVE 4890 prevented cardiac glycoside-induced increases in cell surface area and atrial natriuretic peptide gene expression in rat ventricular myocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: